Literature DB >> 23689035

Interplay effects in proton scanning for lung: a 4D Monte Carlo study assessing the impact of tumor and beam delivery parameters.

S Dowdell1, C Grassberger, G C Sharp, H Paganetti.   

Abstract

Relative motion between a tumor and a scanning proton beam results in a degradation of the dose distribution (interplay effect). This study investigates the relationship between beam scanning parameters and the interplay effect, with the goal of finding parameters that minimize interplay. 4D Monte Carlo simulations of pencil beam scanning proton therapy treatments were performed using the 4DCT geometry of five lung cancer patients of varying tumor size (50.4-167.1 cc) and motion amplitude (2.9-30.1 mm). Treatments were planned assuming delivery in 35 × 2.5 Gy(RBE) fractions. The spot size, time to change the beam energy (τes), time required for magnet settling (τss), initial breathing phase, spot spacing, scanning direction, scanning speed, beam current and patient breathing period were varied for each of the five patients. Simulations were performed for a single fraction and an approximation of conventional fractionation. For the patients considered, the interplay effect could not be predicted using the superior-inferior motion amplitude alone. Larger spot sizes (σ ~ 9-16 mm) were less susceptible to interplay, giving an equivalent uniform dose (EUD) of 99.0 ± 4.4% (1 standard deviation) in a single fraction compared to 86.1 ± 13.1% for smaller spots (σ ~ 2-4 mm). The smaller spot sizes gave EUD values as low as 65.3% of the prescription dose in a single fraction. Reducing the spot spacing improved the target dose homogeneity. The initial breathing phase can have a significant effect on the interplay, particularly for shorter delivery times. No clear benefit was evident when scanning either parallel or perpendicular to the predominant axis of motion. Longer breathing periods decreased the EUD. In general, longer delivery times led to lower interplay effects. Conventional fractionation showed significant improvement in terms of interplay, giving a EUD of at least 84.7% and 100.0% of the prescription dose for the small and larger spot sizes respectively. The interplay effect is highly patient specific, depending on the motion amplitude, tumor location and the delivery parameters. Large degradations of the dose distribution in a single fraction were observed, but improved significantly using conventional fractionation.

Entities:  

Mesh:

Year:  2013        PMID: 23689035      PMCID: PMC3752993          DOI: 10.1088/0031-9155/58/12/4137

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  38 in total

1.  Intensity modulated proton therapy: a clinical example.

Authors:  A J Lomax; T Boehringer; A Coray; E Egger; G Goitein; M Grossmann; P Juelke; S Lin; E Pedroni; B Rohrer; W Roser; B Rossi; B Siegenthaler; O Stadelmann; H Stauble; C Vetter; L Wisser
Journal:  Med Phys       Date:  2001-03       Impact factor: 4.071

2.  Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation.

Authors:  Thomas Bortfeld; Kimmo Jokivarsi; Michael Goitein; Jong Kung; Steve B Jiang
Journal:  Phys Med Biol       Date:  2002-07-07       Impact factor: 3.609

3.  Effects of respiratory motion on dose uniformity with a charged particle scanning method.

Authors:  M H Phillips; E Pedroni; H Blattmann; T Boehringer; A Coray; S Scheib
Journal:  Phys Med Biol       Date:  1992-01       Impact factor: 3.609

4.  Degradation of the Bragg peak due to inhomogeneities.

Authors:  M Urie; M Goitein; W R Holley; G T Chen
Journal:  Phys Med Biol       Date:  1986-01       Impact factor: 3.609

5.  Beam scanning for heavy charged particle radiotherapy.

Authors:  M Goitein; G T Chen
Journal:  Med Phys       Date:  1983 Nov-Dec       Impact factor: 4.071

6.  Reporting and analyzing dose distributions: a concept of equivalent uniform dose.

Authors:  A Niemierko
Journal:  Med Phys       Date:  1997-01       Impact factor: 4.071

7.  Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.

Authors:  M Testa; J Schümann; H-M Lu; J Shin; B Faddegon; J Perl; H Paganetti
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

8.  On cold spots in tumor subvolumes.

Authors:  Wolfgang A Tomé; Jack F Fowler
Journal:  Med Phys       Date:  2002-07       Impact factor: 4.071

9.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.

Authors:  Yvette Seppenwoolde; Hiroki Shirato; Kei Kitamura; Shinichi Shimizu; Marcel van Herk; Joos V Lebesque; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

10.  Compensating for heterogeneities in proton radiation therapy.

Authors:  M Urie; M Goitein; M Wagner
Journal:  Phys Med Biol       Date:  1984-05       Impact factor: 3.609

View more
  36 in total

1.  Motion mitigation for lung cancer patients treated with active scanning proton therapy.

Authors:  Clemens Grassberger; Stephen Dowdell; Greg Sharp; Harald Paganetti
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

Review 2.  Image guidance in proton therapy for lung cancer.

Authors:  Miao Zhang; Wei Zou; Boon-Keng Kevin Teo
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 3.  Empowering Intensity Modulated Proton Therapy Through Physics and Technology: An Overview.

Authors:  Radhe Mohan; Indra J Das; Clifton C Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-10-01       Impact factor: 7.038

4.  Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Authors:  Wei Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Yu-Hui Chang; Zhifei Wen; Jiajian Shen; Joshua B Stoker; Xiaoning Ding; Yanle Hu; Narayan Sahoo; Michael G Herman; Carlos Vargas; Sameer Keole; William Wong; Martin Bues
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-10       Impact factor: 7.038

Review 5.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

6.  Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.

Authors:  Wei Liu; Zhongxing Liao; Steven E Schild; Zhong Liu; Heng Li; Yupeng Li; Peter C Park; Xiaoqiang Li; Joshua Stoker; Jiajian Shen; Sameer Keole; Aman Anand; Mirek Fatyga; Lei Dong; Narayan Sahoo; Sujay Vora; William Wong; X Ronald Zhu; Martin Bues; Radhe Mohan
Journal:  Pract Radiat Oncol       Date:  2014-09-11

7.  Four-dimensional Monte Carlo simulations demonstrating how the extent of intensity-modulation impacts motion effects in proton therapy lung treatments.

Authors:  Stephen Dowdell; Clemens Grassberger; Harald Paganetti
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

8.  Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Authors:  Chenbin Liu; Steven E Schild; Joe Y Chang; Zhongxing Liao; Shawn Korte; Jiajian Shen; Xiaoning Ding; Yanle Hu; Yixiu Kang; Sameer R Keole; Terence T Sio; William W Wong; Narayan Sahoo; Martin Bues; Wei Liu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-02-14       Impact factor: 7.038

9.  Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.

Authors:  Jie Shan; Yunze Yang; Steven E Schild; Thomas B Daniels; William W Wong; Mirek Fatyga; Martin Bues; Terence T Sio; Wei Liu
Journal:  Med Phys       Date:  2020-10-13       Impact factor: 4.071

Review 10.  The Practicality of ICRU and Considerations for Future ICRU Definitions.

Authors:  Annemarie Shepherd; Sara St James; Ramesh Rengan
Journal:  Semin Radiat Oncol       Date:  2018-06       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.